Luca Francesca, Bubba Giuseppina, Basile Massimo, Brdicka Radim, Michalodimitrakis Emmanuel, Rickards Olga, Vershubsky Galina, Quintana-Murci Lluis, Kozlov Andrey I, Novelletto Andrea
Department of Cell Biology, University of Calabria, Rende, Italy.
PLoS One. 2008 Sep 5;3(9):e3136. doi: 10.1371/journal.pone.0003136.
Genetic variation at NAT2 has been long recognized as the cause of differential ability to metabolize a wide variety of drugs of therapeutic use. Here, we explore the pattern of genetic variation in 12 human populations that significantly extend the geographic range and resolution of previous surveys, to test the hypothesis that different dietary regimens and lifestyles may explain inter-population differences in NAT2 variation.
METHODOLOGY/PRINCIPAL FINDINGS: The entire coding region was resequenced in 98 subjects and six polymorphic positions were genotyped in 150 additional subjects. A single previously undescribed variant was found (34T>C; 12Y>H). Several aspects of the data do not fit the expectations of a neutral model, as assessed by coalescent simulations. Tajima's D is positive in all populations, indicating an excess of intermediate alleles. The level of between-population differentiation is low, and is mainly accounted for by the proportion of fast vs. slow acetylators. However, haplotype frequencies significantly differ across groups of populations with different subsistence.
CONCLUSIONS/SIGNIFICANCE: Data on the structure of haplotypes and their frequencies are compatible with a model in which slow-causing variants were present in widely dispersed populations before major shifts to pastoralism and/or agriculture. In this model, slow-causing mutations gained a selective advantage in populations shifting from hunting-gathering to pastoralism/agriculture. We suggest the diminished dietary availability of folates resulting from the nutritional shift, as the possible cause of the fitness increase associated to haplotypes carrying mutations that reduce enzymatic activity.
长期以来,人们一直认为NAT2基因变异是导致多种治疗性药物代谢能力差异的原因。在此,我们探究了12个人类群体的基因变异模式,这些群体显著扩展了先前调查的地理范围和分辨率,以检验不同饮食方案和生活方式可能解释NAT2变异人群间差异这一假设。
方法/主要发现:对98名受试者的整个编码区进行了重测序,并对另外150名受试者的6个多态性位点进行了基因分型。发现了一个以前未描述的变异(34T>C;12Y>H)。通过合并模拟评估,数据的几个方面不符合中性模型的预期。所有群体中Tajima's D均为正值,表明中等频率等位基因过剩。群体间分化水平较低,主要由快速乙酰化者与慢速乙酰化者的比例决定。然而,不同生存方式的人群组间单倍型频率存在显著差异。
结论/意义:关于单倍型结构及其频率的数据与一个模型相符,在该模型中,导致慢速代谢的变异在向畜牧和/或农业重大转变之前就已存在于广泛分散的人群中。在这个模型中,导致慢速代谢的突变在从狩猎采集向畜牧/农业转变的人群中获得了选择优势。我们认为,营养转变导致叶酸饮食供应减少,这可能是与携带降低酶活性突变的单倍型相关的适应性增加的原因。